Oruka Therapeutics (ORKA) Current Leases (2024 - 2026)
Oruka Therapeutics (ORKA) recorded quarterly Current Leases of $680000.0 in Q1 2026, up 9.85% quarter-over-quarter from $619000.0 in Q4 2025, and up 140.28% on a YoY basis from $283000.0 in Q1 2025.
Oruka Therapeutics (ORKA) Current Leases (2024 - 2026) Analysis & Trends
Oruka Therapeutics' Current Leases history runs 3 years deep, the most recent figure standing at $680000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 140.28% year-over-year to $680000.0; the TTM figure through Mar 2026 stood at $680000.0 (up 140.28% YoY), while the FY2025 annual figure was $619000.0, up 190.61% from the prior year.
- Current Leases was $680000.0 for Q1 2026 at Oruka Therapeutics, up from $619000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $680000.0 in Q1 2026 to a low of $146000.0 in Q3 2024.
- Historically, Current Leases has averaged $431428.6 across 3 years, with a median of $419000.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Current Leases jumped 190.61% in 2025, then soared 140.28% in 2026.
- A 3-year view of Current Leases shows it stood at $213000.0 in 2024, then surged by 190.61% to $619000.0 in 2025, then grew by 9.85% to $680000.0 in 2026.
- The last three Current Leases figures came in at $680000.0 (Q1 2026), $619000.0 (Q4 2025), and $419000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Oruka Therapeutics | 4.04 Bn | 3.65 Bn | - | 680,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 680,000.00 |
| Dec 31, 2025 | 619,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 660,000.00 |
| Mar 31, 2025 | 283,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Sep 30, 2024 | 146,000.00 |